Patents Assigned to MARCADIA BIOTECH, INC.
  • Patent number: 9145451
    Abstract: Provided herein are glucagon superfamily peptides conjugated with GPCR ligands that are capable of acting at a G protein-coupled receptor. Also provided herein are pharmaceutical compositions and kits of the conjugates of the invention. Further provided herein are methods of treating a disease, e.g., a metabolic disorder, such as diabetes and obesity, comprising administering the conjugates of the invention.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: September 29, 2015
    Assignees: Indiana University Research and Technology Corporation, Marcadia Biotech, Inc.
    Inventors: Richard D. DiMarchi, Lianshan Zhang
  • Patent number: 8975223
    Abstract: Methods are provided for administering an extended half-life GLP-1/GIP coagonist peptide to a patient in need thereof for reducing weight gain, inducing weight loss, treating hyperglycemia, reducing blood glucose levels, or normalizing blood glucose levels in said patient.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: March 10, 2015
    Assignee: Marcadia Biotech, Inc.
    Inventors: Louis Vignati, Richard D. DiMarchi
  • Publication number: 20140018291
    Abstract: Methods are provided for administering an extended half-life GLP-1/GIP coagonist peptide to a patient in need thereof for reducing weight gain, inducing weight loss, treating hyperglycemia, reducing blood glucose levels, or normalizing blood glucose levels in said patient.
    Type: Application
    Filed: December 22, 2011
    Publication date: January 16, 2014
    Applicant: MARCADIA BIOTECH, INC.
    Inventors: Louis Vignati, Richard D. Dimarchi
  • Publication number: 20130116172
    Abstract: Provided herein are glucagon superfamily peptides conjugated with GPCR ligands that are capable of acting at a G protein-coupled receptor. Also provided herein are pharmaceutical compositions and kits of the conjugates of the invention. Further provided herein are methods of treating a disease, e.g., a metabolic disorder, such as diabetes and obesity, comprising administering the conjugates of the invention.
    Type: Application
    Filed: May 10, 2011
    Publication date: May 9, 2013
    Applicant: MARCADIA BIOTECH, INC.
    Inventors: Richard D. Dimarchi, Lianshan Zhang